Shanghai Serum Bio-Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000059X8
CNY
25.41
1.3 (5.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
194.14
188.61
173.01
207.97
184.97
188.10
144.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
194.14
188.61
173.01
207.97
184.97
188.10
144.33
Raw Material Cost
50.31
51.53
32.79
37.91
33.77
27.65
21.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
53.19
52.64
41.69
40.30
30.53
32.78
26.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.46
0.69
0.69
0.73
0.02
0.02
0.02
Selling and Distribution Expenses
73.07
71.84
69.64
60.82
48.40
57.74
44.11
Other Expenses
-3.32
-2.64
-2.99
-1.74
-0.96
-1.48
-1.42
Total Expenditure (Excl Depreciation)
143.80
150.31
114.88
122.34
103.09
103.43
77.76
Operating Profit (PBDIT) excl Other Income
50.300000000000004
38.3
58.099999999999994
85.60000000000001
81.89999999999999
84.7
66.6
Other Income
20.12
17.86
23.66
9.41
9.84
5.33
12.87
Operating Profit (PBDIT)
86.75
68.27
89.66
106.43
96.72
94.58
70.51
Interest
0.46
0.69
0.69
0.73
0.02
0.02
0.02
Exceptional Items
-4.97
2.59
2.66
0.15
0.00
0.12
0.00
Gross Profit (PBDT)
143.83
137.08
140.22
170.07
151.20
160.45
123.25
Depreciation
20.34
17.40
15.14
15.28
12.75
10.93
9.47
Profit Before Tax
60.98
52.77
76.50
90.58
83.95
83.75
61.03
Tax
6.28
6.64
9.84
11.39
11.58
12.01
10.42
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.29
38.77
64.20
76.48
63.17
65.76
42.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
44.29
38.77
64.20
76.48
63.17
65.76
42.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.29
38.77
64.20
76.48
63.17
65.76
42.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,095.50
1,085.84
1,121.63
369.63
293.15
336.94
256.88
Earnings per share (EPS)
0.41
0.36
0.59
0.71
0.58
0.61
0.39
Diluted Earnings per share
0.41
0.36
0.59
0.71
0.58
0.61
0.39
Operating Profit Margin (Excl OI)
23.84%
17.5%
29.4%
39.3%
40.08%
41.64%
33.38%
Gross Profit Margin
41.89%
37.2%
52.97%
50.9%
52.28%
50.34%
48.85%
PAT Margin
22.81%
20.56%
37.11%
36.78%
34.15%
34.96%
29.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 2.92% vs 9.02% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 14.18% vs -39.56% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 32.14% vs -23.64% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -28.57% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shanghai Serum Bio-Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
194.14
0
194.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
194.14
0
194.14
Raw Material Cost
50.31
0
50.31
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
53.19
0
53.19
Power Cost
0
0
0.00
Manufacturing Expenses
0.46
0
0.46
Selling and Distribution Expenses
73.07
0
73.07
Other Expenses
-3.32
0.00
-3.32
Total Expenditure (Excl Depreciation)
143.80
0
143.80
Operating Profit (PBDIT) excl Other Income
50.34
0.00
50.34
Other Income
20.12
0
20.12
Operating Profit (PBDIT)
86.75
0
86.75
Interest
0.46
0
0.46
Exceptional Items
-4.97
0
-4.97
Gross Profit (PBDT)
143.83
0
143.83
Depreciation
20.34
0
20.34
Profit Before Tax
60.98
0
60.98
Tax
6.28
0
6.28
Provisions and contingencies
0
0
0.00
Profit After Tax
44.29
0
44.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
44.29
0
44.29
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.29
0
44.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,095.50
0
1,095.50
Earnings per share (EPS)
0.41
0
0.41
Diluted Earnings per share
0.41
0
0.41
Operating Profit Margin (Excl OI)
23.84%
0%
0.00
23.84%
Gross Profit Margin
41.89%
0%
0.00
41.89%
PAT Margin
22.81%
0%
0.00
22.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 19.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.92% vs 9.02% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 4.43 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.18% vs -39.56% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 32.14% vs -23.64% in Dec 2023

Annual - Interest
Interest 0.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -28.57% vs 0.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.84%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023